Not all cancer cells are the same, and neither are their responses to drugs. Finding the right drug for the right cancer cell is a long battle in drug development and in designing effective treatments ...

When Cell Death Goes Rogue: The Balancing Act of Apoptosis Programmed cell death, or apoptosis, is essential for renewing our tissues and keeping our bodies running smoothly. Every day, millions of ...

Researchers may have discovered how dense breast tissue leads to cancer, and they hope they can get ahead of tumor formation.

Researchers from the National University of Singapore (NUS) have demonstrated an innovative approach for targeted breast ...

ZFTA–RELA is the cancer-promoting protein product of a gene fusion. Analyses of accessible sites in the DNA–protein complex chromatin in developing mice show that ZFTA–RELA binds to chromatin modules ...

Iron is an essential micronutrient, but excess iron can damage cells and increase cancer risk. While many cells die from iron ...

Study findings might also help inform development of targeted treatments that destroy cancer cells while leaving normal tissue unharmed.

Adelaide University researchers have developed a new way of using mRNA technology to reprogram tumor-supporting immune cells ...

Immunotherapy, which uses programmed immune cells to selectively destroy cancer cells, has transformed cancer treatment. However, cancer cells have developed immune evasion strategies, leading to poor ...

UCLA researchers developed ready-made cancer-fighting T cells from cord blood stem cells that can attack solid tumors through ...

For years, one of the most powerful weapons against certain blood cancers, called CAR-T therapy, has required an elaborate process: Doctors extract a patient’s immune cells, ship them to a specialized ...